Video

Horse ATG for Severe Aplastic Anemia

Publish date: March 17, 2011

 

Rabbit antithymocyte globulin (ATG) was inferior to horse ATG for the initial treatment of patients with severe aplastic anemia, Dr. Phillip Scheinberg says. See the related story at http://tinyurl.com/5r9wrmz

Recommended Reading

Nilotinib for Myeloid Leukemia
MDedge Hematology and Oncology
Ofatumumab
MDedge Hematology and Oncology
CML Treatment: Old Drug, New Name
MDedge Hematology and Oncology
Second-line CML drugs prove better than first
MDedge Hematology and Oncology
Treatment of CML continues to progress
MDedge Hematology and Oncology
Survival improves for AYAs with leukemia and lymphoma
MDedge Hematology and Oncology
Agent shows promise in acute leukemias
MDedge Hematology and Oncology
ODAC votes against one leukemia, one NHL drug
MDedge Hematology and Oncology
Ofatumumab receives accelerated approval from FDA
MDedge Hematology and Oncology
Fostamatinib successfully targets the B-cell receptor
MDedge Hematology and Oncology